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taken up and oxidized bymacrophages in
an MCT1-dependent fashion. Lactate-
mediated macrophage polarization
promotes revascularization and muscle
regeneration. Consequently, EC-specific
loss of pfkfb3 lowers muscle lactate
levels and impairs muscle recovery from
ischemia.ll
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https://doi.org/10.1016/j.cmet.2020.05.004SUMMARYEndothelial cell (EC)-derived signals contribute to organ regeneration, but angiocrine metabolic communication
is not described. We found that EC-specific loss of the glycolytic regulator pfkfb3 reduced ischemic hindlimb
revascularization and impaired muscle regeneration. This was caused by the reduced ability of macrophages
toadoptaproangiogenicandproregenerativeM2-likephenotype.Mechanistically, lossofpfkfb3 reduced lactate
secretion by ECs and lowered lactate levels in the ischemic muscle. Addition of lactate to pfkfb3-deficient ECs
restored M2-like polarization in an MCT1-dependent fashion. Lactate shuttling by ECs enabled macrophages
topromoteproliferationand fusionofmuscleprogenitors.Moreover, VEGFproductionby lactate-polarizedmac-
rophages was increased, resulting in a positive feedback loop that further stimulated angiogenesis. Finally,
increasing lactate levels during ischemia rescued macrophage polarization and improved muscle reperfusion
and regeneration, whereas macrophage-specific mct1 deletion prevented M2-like polarization. In summary,
ECs exploit glycolysis for angiocrine lactate shuttling to steer muscle regeneration from ischemia.Context and Significance
Skeletal muscle regeneration from ischemia is coordinated by strictly timed interactions between several cell types. These in-
teractions are poorly understood but can lead to the development of therapies for regenerative medicine or peripheral artery
disease. Zhang et al. show that endothelial cells (themain cell type of blood vessels) play a crucial role duringmuscle regener-
ation. Besides restoring oxygen and nutrient supply, endothelial cells directly control the function ofmacrophages (specialized
immune cells) by releasing lactate. Endothelial cell-derived lactate is taken up by macrophages via the MCT1-lactate trans-
porter. Upon lactate stimulation,macrophages actively support the formation of newmuscle fibers and further stimulate blood
vessel formation. Our findings imply that endothelial cells use lactate to actively control muscle regeneration.
1136 Cell Metabolism 31, 1136–1153, June 2, 2020 ª 2020 The Author(s). Published by Elsevier Inc.
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Endothelial cells (ECs) cover the inner wall of blood vessels and
act as gatekeepers of metabolism by adapting oxygen and
nutrient delivery to themetabolic needs of tissues through angio-
genesis (Adams and Alitalo, 2007; Potente et al., 2011). Recent
studies have indicated that ECs possess specific metabolic
characteristics (Fitzgerald et al., 2018; Potente and Carmeliet,
2017). Even under quiescent conditions, ECs generate the ma-
jority of their energy via the glycolytic conversion of glucose to
lactate (Culic et al., 1997; De Bock et al., 2013; Kr€utzfeldt
et al., 1990). In addition, ECs further upregulate glycolysis to
fuel migration and proliferation during angiogenesis. The in-
crease in glycolysis upon EC activation is mediated by the glyco-
lytic regulator phosphofructokinase-2/fructose-2,6-bisphospha-
tase isoform 3 (PFKFB3) (De Bock et al., 2013; Schoors et al.,
2014). Deletion of pfkfb3 in ECs (pfkfb3DEC) prevents blood
vessel growth during development as well as in various models
of pathological angiogenesis (Cantelmo et al., 2016; De Bock
et al., 2013; Schoors et al., 2014; Xu et al., 2014). Although the
exact reasons for the dependence of ECs on glycolysis remain
to be fully elucidated, it has been hypothesized that high glycol-
ysis would support efficient oxygen transfer to surrounding tis-
sues or allow ECs to rapidly invade avascular and hypoxic areas
during vessel formation. However, whether ECs exploit glycol-
ysis to engage in metabolic crosstalk with other cells within their
microenvironment is unknown.
It has become increasingly recognized that ECs also regulate
tissue homeostasis in an angiogenesis-independent manner
through the production and release of angiocrine factors. Those
factors are actively involved in the maintenance as well in the
activation, specification, and guidance of organ regeneration,
often in an organotypic and context-dependent manner (Au-
gustin and Koh, 2017; Rafii et al., 2016). For instance, angio-
crine growth factors promote liver and lung regeneration by
orchestrating self-renewal and differentiation of tissue-specific
resident stem and progenitor cells into functional organs
(Ding et al., 2010; Ding et al., 2011; Hu et al., 2014; LeCouter
et al., 2003). Angiocrine signals also ensure neuronal stem
cell quiescence (Delgado et al., 2014; Ottone et al., 2014), while
during regenerative neurogenesis, they promote neuronal
stem cell proliferation, activation, and differentiation (Rafii
et al., 2016).
Skeletal muscle is a highly vascularized tissue and is charac-
terized by a remarkable capacity for regeneration (Almada and
Wagers, 2016; Itagaki et al., 1995). Muscle regeneration is
dependent on the activation and proliferation of resident mus-
cle stem cells that give rise to a population of proliferating
myogenic progenitor cells (MPCs) (Almada and Wagers,
2016). A subset of these MPCs self-renews to replenish the
muscle stem cell pool, whereas the other MPCs enter
myogenic differentiation and fuse with each other or with re-
maining myofibers to repair the damaged muscle (Yin et al.,
2013). This sequence of events is coordinated by strictly timed
cellular interactions between several cell types within the mus-
cle microenvironment, including macrophages (Bentzinger
et al., 2013). Macrophages initially exhibit a more pro-inflam-
matory M1-like phenotype but soon thereafter functionally
repolarize toward an M2-like phenotype to actively supportmuscle regeneration (Arnold et al., 2007). Blood vessels also
undergo profound alterations during muscle regeneration (La-
troche et al., 2015a; Latroche et al., 2015b), and this is partic-
ularly true after ischemia-induced muscle damage, where mus-
cle regeneration coincides with the formation of new blood
vessels. Angiogenesis restores oxygen and nutrient delivery
to the regenerating muscle tissue (Adams and Alitalo, 2007; Po-
tente et al., 2011), and angiocrine growth factors promote the
proliferation of muscle progenitor cells (Arsic et al., 2004; Bor-
selli et al., 2010; Latroche et al., 2017). ECs also control macro-
phage differentiation and maturation via angiocrine Notch
signaling to promote arteriogenesis during hindlimb ischemia
(Krishnasamy et al., 2017). However, whether ECs engage
into metabolic angiocrine crosstalk to control ischemia-induced
muscle regeneration is unknown.
Here, we show that ECs exploit their glycolytic capacity to
steer muscle regeneration during ischemia. Upon EC activation,
the angiocrine release of lactate, the main metabolic product of
glycolytic glucose catabolism, initiates a lactate shuttle that pro-
motes an MCT1-dependent oxidative switch in macrophages
and instructs their polarization toward a pro-regenerative M2-
like phenotype. These macrophages promote muscle regenera-
tion by stimulating the proliferation and differentiation of MPCs.
Moreover, lactate-polarized macrophages also upregulate the
expression of vascular endothelial growth factor (VEGF), thereby
creating a positive feedback loop that further stimulates
angiogenesis.
RESULTS
PFKFB3 Controls Glycolysis in Muscle ECs
To study the metabolic angiocrine properties of ECs, we
generated pfkfb3LoxP/LoxP mice and intercrossed them with EC-
specific inducible pdgfb-CreERT2 mice (Claxton et al., 2008),
hereafter referred to as pfkfb3DEC mice (Figure 1A). Ten days af-
ter the last tamoxifen injection, we isolated ECs from calf muscle
(m. gastrocnemius and m. soleus) (mECs) and confirmed a
decrease in pfkfb3 mRNA levels in mECs from pfkfb3DEC mice
(hereafter termed mECsDpfkfb3) when compared to mECs iso-
lated from pfkfb3WT mice (hereafter termed mECsWT). This re-
sulted in an almost complete loss of PFKFB3 protein content
(Figures S1A and S1B). Loss of endothelial pfkfb3 did not affect
baseline muscle vascular density (Figures S1C and S1D) nor did
it affect the number of CD31+CD45mECs (Figure S1E). Isolated
mECsDpfkfb3 showed lower extracellular acidification rate (ECAR)
(Figure S1F) and a reduction in glycolytic flux (Figure S1G),
consistent with previous data using short-hairpin-mediated
knockdown of pfkfb3 in human umbilical vein endothelial cells
(De Bock et al., 2013). Collectively, these data demonstrate
that PFKFB3 controls glycolysis in mECs.
Deletion of Endothelial pfkfb3 Impairs Hindlimb
Ischemia (HLI)-Induced Revascularization
To induce hindlimb ischemia (HLI), we ligated the femoral artery,
which leads to reduction of blood flow by >80%, causing pro-
found ischemia-induced muscle damage. This damage is fol-
lowed by robust revascularization and muscle regeneration,
leading to full recovery of muscle function after four weeks (Lim-
bourg et al., 2009; Zhang et al., 2017) (Figure 1A). Laser DopplerCell Metabolism 31, 1136–1153, June 2, 2020 1137
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in both pfkfb3WT and pfkfb3DEC mice. However, although it grad-
ually recovered in pfkfb3WT mice during the 4-week follow up
period, blood flow remained severely impaired in pfkfb3DEC
mice (Figures 1B and 1C).Pfkfb3DECmice also displayed a higher
frequency of necrotic toes (Figure 1D). Reduced revasculariza-
tion was not caused by differences in EC apoptosis after HLI
(Figures S1H–S1J). Instead, mECsDpfkfb3 proliferated less, as
indicated by fewer Ki67+CD31+ cells (Figure 1E), which was
associated with reduced vascular density in pfkfb3DEC muscle
7 days after HLI (Figures 1F and S1K). Morphological analysis
on whole-mounted muscle bundles additionally showed that
lower vascular density coincided with reduced intercapillary
anastomosis (Figures 1G and S1L). Concomitantly, pfkfb3DEC
mice developed increased muscle necrosis that resolved slower
over time (Figures 1H and S1M–S1O). Importantly, muscle dam-
age 1 day after HLI was similar between pfkfb3DEC and pfkfb3WT
mice (Figures 1H, S1M and S1N), showing that impaired regen-
eration was not secondary to differences in initial muscle dam-
age. The regenerative area in wild-type (WT) animals reached a
maximum 7 days after HLI, and normal muscle morphology
was almost completely restored after 4 weeks, whereas
pfkfb3DEC mice still showed large areas of intense regeneration
(Figures 1H, 1I, S1M, and S1O). Consequently, the muscle fiber
cross-sectional area was lower in pfkfb3DEC mice (Figure 1J).
Thus, endothelial PFKFB3 is required for ischemia-inducedmus-
cle revascularization and regeneration.
We next performed pimonidazole injections 3 days after HLI
to detect hypoxic areas within the injured muscles. As ex-
pected, reduced revascularization in pfkfb3DEC mice coincided
with extensive and widespread hypoxia (Figures 1K and S1P).
Despite this, we surprisingly measured less VEGF in the
ischemic hindlimb of pfkfb3DEC mice (Figure 1L). Vegf is highly
expressed in MPCs (Verma et al., 2018), but we did not find dif-
ferences between genotypes (Figure S1Q). Macrophages also
produce and respond to VEGF (Casazza et al., 2013; Ganta
et al., 2019; He et al., 2012). Deletion of vegf in macrophages
by using the myeloid-specific LysM-Cre line (vegfDMac) (Stock-
mann et al., 2008) reduced muscle VEGF levels upon HLI (Fig-
ure 1M). We thus decided to investigate whether endothelial
pfkfb3 affects macrophage function in the muscle upon
ischemia.Figure 1. Endothelial PFKFB3 Controls EC Glycolysis and Ischemia-In
(A) Scheme showing the generation of pdgfb-CreERT2 3 pfkfb3LoxP/LoxP (pfkfb3DE
(B and C) Representative images (B) and quantification (C) of hindlimb blood per
after HLI surgery (n = 7).
(D) Distribution of necrotic toes per paw 14 days after HLI (n = 7).
(E) Representative images of Ki67 (green), CD31 (red), and hoechst (blue) immun
scale bar, 50 mm).
(F and G) Representative CD31 immunofluorescent images on muscle cross sec
bundles (G) at 28 days (scale bar, 10 mm) in pfkfb3WT and pfkfb3DEC mice.
(H and I) Representative hematoxylin-eosin (H&E) staining images (H) at the indic
bar, 10 mm.
(J) Muscle fiber size distribution at 28 days (n = 4).
(K) Representative images of pimonidazole staining (yellow) and hoechst (blue) a
(L and M) Muscle VEGF protein content in pfkfb3WT and pfkfb3DEC mice (L) or in
Student’s t test (two-tailed, unpaired) in (I) (*p% 0.05). Two-way ANOVAwith Tuke
measures ANOVA with Sidak’s multiple comparisons test in (C) (*p < 0.05). Each
SEM. See also Figure S1.Endothelial PFKFB3 Is Crucial forM2-like Polarization of
Macrophages in the Muscle
Macrophages play a crucial role during skeletal muscle regener-
ation after injury (Chazaud, 2014; Tidball, 2017). To study
whether loss of endothelial pfkfb3 affects immune cell recruit-
ment/infiltration and macrophage differentiation, we first
confirmed with a Rosa26mTmG fate-tracing mouse line and
mRNAmeasurements that pdgfb-CreERT2 activity was restricted
to ECs and was largely absent in macrophages and the total
CD45+ immune-cell compartment (Figures S2A and S2B).
Next, we performed a time course experiment where we evalu-
ated the dynamics of various myeloid cell populations within
the hindlimb upon HLI. Initially, muscle damage leads to the infil-
tration of neutrophils and CX3CR1+Ly-6Chigh monocytes, most
of which also expressed CCR2 (Figures 2A, 2B, S2C–S2E).
These monocytes gradually differentiate into macrophages indi-
cated by downregulation of Ly-6C and upregulation of F4/80 and
MERTK expression (Figures S2C–S2E) (Krishnasamy et al.,
2017). Although the number of monocytes, neutrophils, and
macrophages increased comparably in the ischemic muscle of
pfkfb3WT and pfkfb3DEC mice until day 2, it was more pro-
nounced in pfkfb3DEC mice at day 3 (Figures 2A–2C), reflecting
a general and maintained pro-inflammatory state. Notably, we
found no difference in monocyte proliferation (Figures 2D and
S2F) between pfkfb3WT and pfkfb3DEC mice, suggesting that
the enhanced number of monocytes in pfkfb3DEC mice is the
result of increased recruitment. The increased macrophage
number 3 days after HLI was confirmed by immunofluorescent
detection of F4/80+ cells in the ischemic area (Figures 2E and
2F). We also detected a small and transient delay in monocyte-
to-macrophage differentiation since the gradual decline of Ly-
6C versus the increase in F4/80, and MERTK expression was
slightly lower in pfkfb3DEC muscle at day 2 but recovered to
pfkfb3WT levels by day 3 (Figure 2G).
Further characterization of the macrophage population at
3 days after HLI showed a strong reduction in the relative
number of Relma+CD206+ as well as RelmaCD206+ M2-like
macrophage in pfkfb3DEC muscle (Figures 2H–2J) and lower
CD206 protein expression in the total macrophage population
(Figures 2K and 2L). CD206 staining on FACS-sorted
CD45+ cells (Figures 2M and 2N) or on tissue sections (Figures
2O and 2P) confirmed that, despite the increase in totalduced Revascularization
C) mice and experimental setup.
fusion in pfkfb3WT and pfkfb3DEC mice using laser Doppler imaging before and
ostainings and quantification of Ki67+CD31+ ECs in muscles at 3 days (n = 3;
tions (F) at the indicated times (scale bar, 50 mm) and whole mounted muscle
ated times and quantification of regenerating area 28 days after HLI (I). Scale
t 3 days (scale bar, 50 mm).
vegfWT and vegfDMac mice (M) 72 h after HLI.
y’s multiple comparisons test in (J), (L), and (M) (*p < 0.05). Two-way repeated-
dot represents a single mouse ([I], [L], and [M]). Bar graphs represents mean ±
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Figure 2. Endothelial PFKFB3 Is Crucial for M2-like Polarization of Macrophages in the Muscle
(A–C) Total number of neutrophils (A), monocytes (B), and macrophages (C) in muscle at the indicated times after HLI determined by flow cytometry.
(D) Quantification of EdU+ monocytes (% of total monocytes) at the indicated times after HLI.
(legend continued on next page)
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phages in pfkfb3DEC muscle 3 days after HLI. Proliferation of
macrophages in the muscle was very low, and even though
CD206+ macrophages proliferated more than the CD206 mac-
rophages, their proliferation rate was not affected in pfkfb3DEC
mice (Figures 2Q, S2G, and S2H), indicating that loss of endo-
thelial pfkfb3 impairs development rather than proliferation of
M2-like macrophages. To evaluate whether the difference in
expression of typical M2 markers coincided with a transcrip-
tional M2-like signature, we isolated macrophages from
pfkfb3WT and pfkfb3DEC muscle 3 days after HLI and performed
RNA-seq. Principal-component analysis showed that pfkfb3WT-
and pfkfb3DEC-derived macrophages clustered separately (Fig-
ure 2R). Moreover, 1,989 genes were differentially regulated
between genotypes (Figure 2S). There was a coordinated acti-
vation of M2 macrophage-related genes (Liu et al., 2017; Varga
et al., 2016) in pfkfb3WT-derived macrophages whereas
pfkfb3DEC-derived macrophages showed higher expression of
M1-related genes (Figure 2T). Gene Ontology pathway analysis
confirmed that pathways associated to an M2-like phenotype
were more activated in in pfkfb3WT-derived macrophages (Fig-
ures S3A and S3B). Taken together, these data indicate that
loss of endothelial pfkfb3 increases monocyte recruitment dur-
ing ischemia but impairs macrophage polarization toward a
M2-like phenotype.
Restoring M2 Macrophage Content in Muscle of
pfkfb3DEC Mice Improves Perfusion and Regeneration
To dissect the functional relevance of impaired M2-like polariza-
tion to impaired recovery from ischemia in pfkfb3DEC mice, we
performed adoptive transplantation experiments. We injected
either unpolarized (ctrl) bone-marrow-derived macrophages
(BMDMs) or IL-4-cultured BMDMs (classical M2, BMDMs(IL-4))
into the hindlimb of mice 3 days after HLI (Figure 3A). Hindlimb
perfusion measurements showed lower perfusion in pfkfb3DEC
mice upon transfer of unpolarized BMDMs in comparison to
pfkfb3WT mice. However, transfer of BMDMs(IL-4) improved hin-
dlimb reperfusion in pfkfb3DEC mice (Figures 3B and 3C) and
increased vascularization (Figures 3D and 3E). BMDM(IL-4) trans-
fer also sufficed to increase VEGF protein levels (Figure 3F),
consistent with increased VEGF secretion by BMDM(IL-4) (Fig-
ure S4A). In addition, BMDM(IL-4) transfer led to a striking accel-
eration of muscle regeneration (Figures 3G–3I and S4B). These
data show that loss of endothelial pfkfb3 controls muscle revas-(E and F) Representative images of F4/80 immunostainings (red) and hoechst (b
(G) Mean fluorescent intensity (MFI) of Ly-6C, F4/80, and MERTK in muscle mac
(H) Representative flow cytometric analysis of CD206+ and Relma+ cells in musc
(I and J) Quantification of Relma+CD206+ (I) and RelmaCD206+ (J) F4/80+CD11
(K and L) Representative histograms (K) and quantification of CD206 MFI (L) in th
(M and N) Representative immunostainings for F4/80 (green) and CD206 (red) on
MFI (N).
(O and P) Representative images of CD206 immunostainings (red) and hoechst (bl
(Q) Quantification of EdU+CD206+ macrophages (% of CD206+ macrophages) a
(R and S). Principal-component analysis (R) and Volcano plot from RNA-seq an
pfkfb3WT and pfkfb3DEC muscles 3 days after HLI (n = 3).
(T) Expression pattern of pro-inflammatory and anti-inflammatory markers genes
Arrowheads point at CD206+ cells (O). Scale bar, 50 mm. Student’s t test (two-taile
Tukey’smultiple comparisons test in (A), (B), (C), (D), and (G) (*p < 0.05). Each dot re
graphs represent mean ± SEM. See also Figures S2 and S3.cularization and regeneration at least partially via controlling
macrophage polarization.
Endothelial Lactate Controls Macrophage Polarization
upon Muscle Ischemia
To study whether mECs exploit angiocrine mechanisms to affect
macrophage polarization, we isolated mECsWT and mECsDpfkfb3
and co-cultured them with BMDMs (Figure S5A). Subsequently,
CD11b+F4/80+ BMDMs were sorted and analyzed. Co-culturing
BMDMs with mECsWT led to the upregulation of several M2-
marker genes including mgl1 (CD301a), mgl2 (CD301b), arg1,
and vegf, whereas co-culture of mECsDpfkfb3 with BMDMs only
modestly activated an M2-gene expression fingerprint (Fig-
ure S5B). The expression of genes associated with an M1-like
phenotype (tnf-a and il-1b) was not different between BMDMs
co-cultured with mECWT versus mECsDpfkfb3 (Figure S5B). This
was not dependent on physical contact between mECs and
BMDMs, because the utilization of conditioned medium (CM)
from mEC cultures led to similar results (Figures 4A and 4B),
demonstrating that endothelial PFKFB3 controls macrophage
polarization via a secreted factor. Interestingly, BMDM stimula-
tion with mECs-CM did not fully recapitulate classical IL-4-medi-
ated M2 polarization, because the activation of several
M2-related genes was significantly lower upon mECs-CM
administration when compared to IL-4 stimulation despite equal
CD206 membrane expression (Figures S5C–S5E).
Among other stimuli, macrophage polarization occurs in
response to cytokine stimulation. We therefore analyzed the
cytokine profile of CM from mECsWT and mECsDpfkfb3 isolated
from ischemic muscles but did not detect any differences (Fig-
ures S5F and S5G). Subsequently, we passed the CM from
mECsWT and mECsDpfkfb3 through a 3-kDa filter to concentrate
the protein fraction and remove metabolites. Strikingly, CM of
mECsWT containing only >3-kDa proteins (CM>3kDa) failed to
induce arg1 and mrc1 expression in BMDMs (Figures 4C and
4D). In fact, arg1 and mrc1 expression by BMDMs was equally
low after stimulation with CM>3kDa from either mECsWT or
mECsDpfkfb3. These data show that removal of metabolites
from CM of mECs blunts their capacity to induce M2-like polar-
ization. Moreover, the mEC-derived metabolite(s) that control
macrophage polarization is/are not (or to a lesser extent)
secreted by mECsDpfkfb3.
Because PFKFB3 is a main glycolytic regulator in ECs and
controls EC-derived lactate production, we hypothesized thatlue) (E) and quantification of F4/80+ area (F) on muscle at 3 days.
rophages at the indicated times after HLI determined by flow cytometry.
le 3 days after HLI.
b+ macrophages.
e total muscle macrophage population 3 days after HLI.
CD45+ cells (M) sorted from muscle 3 d after HLI and quantification of CD206
ue) (O) and quantification of CD206+ macrophages number (P) 3 days after HLI.
t 3 days after HLI determined by flow cytometry
alysis showing differential gene expression (S) of macrophages isolated from
in muscle macrophages 3 days after HLI (n = 3).
d, unpaired) in (F), (I), (J), (L), (N), (P), and (Q) (*p < 0.05). Two-way ANOVA with
presents a singlemouse ([A], [B], [C], [D], [F], [G], [I], [J], [L], [N], [P], and [Q]). Bar
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Figure 3. Restoring M2 Macrophage Content in Muscle of pfkfb3DEC Mice Improves Muscle Perfusion and Regeneration
(A) Scheme showing macrophage transfer experiments.
(B andC) Representative laser Doppler images (B) and quantification of hindlimb perfusion (C) in pfkfb3WT and pfkfb3DECmice upon BMDMs (ctrl) or BMDMs (IL-4)
transfer (n = 5).
(legend continued on next page)
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Indeed, in tumor-associated macrophages, lactate derived
from highly glycolytic tumor cells promotes M2-like polarization
through stabilizing HIF-1a in normoxia or via activating
GPR132 (Chen et al., 2017; Colegio et al., 2014). However, a
role for endothelial-derived lactate in determining macrophage
functional polarization in vivo has not been described. In agree-
ment with reduced glycolysis, we found lactate levels to be lower
in CM derived from mECsDpfkfb3 than in that derived from
mECsWT (Figure 4E). We also performed metabolomic profiling
of CM from mECsDpfkfb3 and mECsWT focusing on metabolites
that are known to play a role in macrophage function (Van den
Bossche et al., 2017; Viola et al., 2019), but we did not find other
metabolites that were reduced in mECsDpfkfb3-CM (Table S1).
Importantly, addition of lactate (5 mM) to mECsWT CM>3kDa, as
well as to both CM and CM>3kDa frommECsDpfkfb3, restored their
capacity to induce arg1 andmrc1 (Figures 4C and 4D) as well as
CD206 cell surface expression in BMDMs (Figure 4F). Similar ob-
servations were made for mgl1 and mgl2, although to a lesser
extent in CM and CM>3kDa from mECsDpfkfb3 (Figures S5H and
S5I). Of note, adding lactate to mECswt-CM did not further in-
crease arg1 andmrc1 expression (Figures 4C and 4D). Reducing
endothelial lactate production via knocking down ldha or mct4
also reduced the activation of M2 marker genes (Figures S5J
and S5K). Importantly, the ability of lactate to promote M2-like
polarization required the presence of mECs-CM, because sup-
plementing lactate (5–10 mM) to BMDMs in the absence of
mECs-CM did not affect arg1 or CD206 expression (Figures
S5L and S5M).
Alternatively, activated M2 macrophages display enhanced
mitochondrial oxidative phosphorylation (OXPHOS) in compari-
son to M1 macrophages (Diskin and Pa˚lsson-McDermott,
2018; O’Neill and Pearce, 2016). Because lactate, after conver-
sion to pyruvate, can enter the tricarboxylic acid (TCA) cycle
via pyruvate dehydrogenase, we also evaluated whether angio-
crine lactate would promote oxygen consumption rate (OCR) in
BMDMs. As expected, mECswt-CM-treated BMDMs showed
higher OCR than mECsDpfkfb3-CM-treated BMDMs. Addition of
lactate to mECsDpfkfb3-CM during the culture of the BMDMs
restored OCR to similar levels when compared to mECswt-CM-
treated BMDMs (Figures 4G and S5N). These data were
confirmed by our transcriptomic data in primary isolated macro-
phage from ischemic muscle which displayed lower expression
of OXPHOS-related genes in pfkfb3DEC (Figures 4H, S3A,
and S3B).
Angiocrine-Lactate-Induced Macrophage Polarization
Promotes Muscle Regeneration and VEGF Secretion
After muscle injury, macrophages that initially present with a pro-
inflammatory M1-like phenotype need to switch to a repair-pro-
moting M2-like state, and interference with this M1 to M2 fate(D and E) Representative images of CD31 immunofluorescent staining (D) and q
(F) VEGF protein content in muscle 5 days after HLI.
(G and H) H&E staining of regenerating muscle (scale bar, 10 mm) (G) and quanti
(I) Muscle fiber size distribution at 12 days (n = 4).
Two-way ANOVA with Tukey’s multiple comparisons test in (E), (F), and (H) (*p
repeated-measures ANOVA with Sidak’s multiple comparisons test in (C) (*p < 0.0
mean ± SEM. See also Figure S4.switch impairs muscle regeneration (Arnold et al., 2007; Deng
et al., 2012; Mounier et al., 2013). In fact, classically LPS/IFNg-
activated M1 macrophages promote MPC growth and prolifera-
tion but inhibit MPCdifferentiation and fusion (Arnold et al., 2007),
whereas IL-4-stimulated M2 macrophages promote MPC differ-
entiation and fusion (Saclier et al., 2013). To assess whether an-
giocrine-lactate-induced macrophage polarization also affects
the ability of MPCs to promote muscle regeneration, we again
incubated BMDMs with CM from mECsWT and mECsDpfkfb3
to promote polarization (mECswt-CM / BMDMs and
mECsDpfkfb3-CM/ BMDMs). Subsequently, mEC-derived CM
was removed and BMDM-derived CM was generated
(mECswt-CM / BMDMs-CM and mECsDpfkfb3-CM /
BMDMs-CM) and added to MPCs (Figure 4A). When compared
to CM derived from unstimulated macrophages, mECswt-CM/
BMDMs-CM stimulated MPC proliferation (Figures 4I and 4J)
and improved MPCfusion into myotubes (Figures 4K and 4L).
Interestingly, mECsDpfkfb3-CM / BMDMs-CM failed to stimu-
late MPC proliferation and fusion. The addition of lactate to
mECsDpfkfb3-CM during polarization of BMDMs, however,
restored the capacity of mECsDpfkfb3+lac-CM/ BMDMs-CM to
drive MPC proliferation and fusion (Figures 4I–4L). Importantly,
adding lactate toMPC culturemedium did not affect proliferation
or differentiation of MPCs (Figures S5O and S5P). Thus, angio-
crine lactate controls the ability of macrophage to promote
MPC proliferation and fusion.
Because we observed lower VEGF levels in pfkfb3DEC muscle,
we also wondered whether angiocrine lactate would promote
VEGF secretion from macrophages. Macrophages isolated
from the ischemic hindlimb of pfkfb3DEC mice expressed lower
vegf (Figure 4M), consistent with literature showing lower vegf
expression by M1-like macrophages (He et al., 2012). Incubation
of BMDMs with mECsDpfkfb3-CM also resulted in lower VEGF
secretion as compared to BMDMs stimulated with mECswt-
CM, and this was rescued by adding lactate to the CM (Fig-
ure 4N). These data show that angiocrine lactate promotes
M2-like macrophage functional polarization, which leads to
increased VEGF secretion and creates a positive feedback
loop to further stimulate angiogenesis.
Increasing Muscle Lactate Levels in pfkfb3DEC Mice
RestoresM2Macrophage Content and ImprovesMuscle
Reperfusion and Regeneration
We next asked whether angiocrine lactate could control macro-
phage polarization in the muscle during ischemia. To address
this, we harvested ischemic muscle and assessed muscle
lactate levels. Whereas induction of ischemia led to a pro-
nounced increase in local muscle lactate levels in WT animals,
this increase was almost completely abrogated in pfkfb3DEC
mice (Figure 5A). Accordingly, circulating blood lactate levels af-
ter HLI were lower in pfkfb3DEC mice (Figure 5B). In agreementuantification of CD31+ area (E) in muscle 12 days after HLI (scale bar, 50 mm).
fication of regenerating area (H) at 12 days.
< 0.05) and in (I) (*p < 0.05 versus pfkfb3WT; #p < 0.05 versus ctrl). Two-way
5). Each dot represents a single mouse ([E], [F], and [H]). Bar graphs represents
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Figure 4. Endothelial Lactate Controls Macrophage Polarization and Function upon Muscle Ischemia
(A) Scheme illustrating experimental set-up.
(B) Gene profiling of unstimulated BMDMs (vehicle) or BMDMs stimulated with mECswt-CM, mECsDpfkfb3-CM.
(legend continued on next page)
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with higher vascular density (and low glycolytic potential) such as
m. soleus when compared to muscles with low vascular density
(and high glycolytic potential) (Figure 5C). Finally, activation of
angiogenesis in the absence of muscle damage by injecting
vegf-expressing myoblasts increased muscle vascular density
(Figures S6A and S6B), and lactate levels were higher in pfkfb3WT
muscle (Figure 5D).
Next, we tested whether lactate supplementation in pfkfb3DEC
mice would restore M2-like polarization and muscle regenera-
tion. We implanted growth-factor-reduced Matrigel plugs
containing lactate in the subcutis of mice immediately after HLI
(Figure S6C)). As previously described (Porporato et al., 2012),
such plugs allow the slow release of lactate, leading to a small
but consistent increase in blood lactate levels (Figure S6D).
Three days after HLI, we found that lactate administration in
pfkfb3DEC mice restored total numbers of macrophages and
macrophage CD206 expression to similar levels in control mice
(Figures 5E–5G). This confirms that lactate is sufficient to drive
M2-like polarization in vivo. Moreover, lactate significantly
improved but did not completely restore perfusion in pfkfb3DEC
mice (Figures 5H and 5I). In agreement with the perfusion data,
vascular density remained slightly lower (Figure 5J). Lactate suf-
ficed to increase VEGF protein levels (Figure 5K). Harvesting
muscle tissue at 12 days after ischemia showed that lactate
led to a striking acceleration of muscle regeneration and higher
muscle fiber cross-sectional area (Figures 5L–5M, S6E, and
S6F). Thus, restoring lactate levels in muscle from pfkfb3DEC res-
cues macrophage polarization and muscle regeneration.
Lactate-Induced Macrophage Polarization Is MCT1
Dependent
To explore how angiocrine lactate affects macrophage polariza-
tion in muscle, we investigated whether EC-derived lactate is
taken up by macrophages. We found that 14C-lactate uptake in
freshly isolated primary muscle macrophages was higher in
pfkfb3WT versus pfkfb3DEC mice 3 days after HLI (Figure 6A).
This was confirmed in BMDMs, where mECswt-CM but not
mECsDpfkfb3-CM promoted lactate uptake (Figure 6B). MCT1
regulates lactate uptake in T cells, and inhibition of MCT1 during
T lymphocyte activation results in selective and profound inhibi-
tion of the extremely rapid phase of T cell division essential for an(C and D) Gene expression analysis of arg1 (C) andmrc1 (D) in BMDMs stimulated
(5 mM) where indicated.
(E) Lactate concentration in mECswt-CM and mECsDpfkfb3-CM.
(F) Representative images of immunostainings of F4/80 (green), CD206 (red), and
without lactate supplementation and quantification of CD206 MFI (n = 3).
(G) OCR upon injection of oligomycin (oligo), FCCP, and rotenone plus antimycin A
stimulation (n = 4–5).
(H) RNaseq data showing OXPHOS gene expression in muscle macrophages 3
(I and J) Representative images (I) and quantification (J) of proliferating MPCs upo
nuclei (red, EdU+; blue, hoechst).
(K and L)MPC fusion analysis: representative images of immunofluorescent DESM
nuclei per DESMIN+ myotube (L).
(M) Vegf gene expression in CD45+ cells sorted from pfkfb3WT and pfkfb3DEC musc
mECsDpfkfb3-CM with or without lactate supplementation.
Scale bar, 50 mm. Student’s t test (two-tailed, unpaired) in (E) and (M). One-way
Tukey’smultiple comparisons test in (C), (D), (G), (J), (L), and (N) (*p < 0.05) aswell a
a single mouse (M) or the average of an independent experiment ([B], [C], [D], [E
Table S1.effective immune response (Murray et al., 2005). We thus hy-
pothesized that MCT1 could control lactate uptake in macro-
phages. We first confirmed that the MCT1 inhibitor AZD3965
reduced lactate uptake in BMDMs stimulated with mECswt-CM
(Figure 6B). Based on higher OCR in lactate-stimulated macro-
phages, we next asked whether the incorporated lactate is actu-
ally used for oxidation. By using radioactive substrate tracing
experiments, we found that M2-like macrophages oxidize
lactate in an MCT1-dependent fashion, and lactate oxidation
was lower in mECsDpfkfb3-CM-treated BMDMs (Figure 6C). And
third, MCT1-mediated lactate uptake is required formacrophage
polarization because AZD3965 reduced the fraction of
CD206+F4/80+ macrophages induced by mECswt-CM to similar
levels compared to incubation with mECsDpfkfb3-CM (Figure 6D).
To confirm that MCT1-dependent lactate uptake also affected
functional properties of macrophages, we used CM from
BMDMs that were stimulated with mECswt-CM, mECsDpfkfb3-
CM either not supplemented with AZD3965 (mECswt+AZD-CM,
mECsDpfkfb3+AZD-CM), or ctrl (DMSO). mECswt+AZD-CM failed
to stimulate MPC proliferation (Figures 6E and 6F) and differen-
tiation (Figures 6G and 6H), as compared to stimulation with
mECsWT CM / BMDMs-CM. Moreover, BMDMs stimulated
with mECswt+AZD-CM secreted less VEGF (Figure 6I). Taken
together, lactate uptake through MCT1 does not only promote
M2-like polarization but also instructs M2-like macrophage-
dependent functions.
Finally, we investigated whether lactate also controls macro-
phage polarization and muscle recovery from ischemia in an
MCT1-dependent fashion in vivo. To this end, we generated
mice lacking Mct1 in macrophages (mct1DMac mice; Figures 7A
and 7B) (and neutrophils) by intercrossing mct1-floxed mice
with myeloid-cell-specific LysM-Cre mice. Consistent with our
observations in pfkfb3DEC mice, we found that 3 days after HLI,
mct1DMac muscles contained more neutrophils, monocytes,
and macrophages (Figure 7C). Moreover,mct1-deficient macro-
phages expressed less CD206 and Relma (Figures 7D–7F). This
shows that MCT1-dependent lactate uptake is required for M2-
like functional polarization of macrophages upon muscle
ischemia. In addition, hindlimb perfusion of mct1DMac mice
recovered slower (Figures 7G and 7H), and CD31 stainings
confirmed thatmct1DMac reduced revascularization 28 days after
HLI (Figure 7I). In agreement with our in vitro and in vivo datawith fractionatedmECswt-CM andmECsDpfkfb3-CM, supplementedwith lactate
hoechst (blue) in BMDMs stimulated with mECswt-CM, mECsDpfkfb3-CMwith or
after mECswt-CM, mECsDpfkfb3-CM, mECswt+lac-CM, and mECsDpfkfb3+lac-CM
days after HLI (n = 3).
n incubation with macrophage-derived CM, measured as percentage of EdU+
IN staining (K) (red, DESMIN; blue, hoechst) and quantification of the number of
le at 3 d. (N) VEGF secretion by BMDMs after stimulation with mECswt-CM and
ANOVA with Tukey’s multiple comparisons test in (B). Two-way ANOVA with
s in (F) (*p < 0.05 versusmECswt-CM; #p < 0.05 versus ctrl). Each dot represents
], [J], [L], and [N]). Bar graphs represent mean ± SEM. See also Figure S5 and
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Figure 5. Increasing Muscle Lactate Levels in pfkfb3DEC Mice Restores M2 Macrophage Content and Improves Muscle Reperfusion and
Regeneration
(A–C) Lactate levels in calf muscle (A), blood serum (B), and in m. extensor digitorum longus (EDL) and m. soleus (C) before and 12 h after HLI.
(legend continued on next page)
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MCT1 inhibition, mct1DMac muscle displayed reduced muscle
regeneration. Indeed, mct1DMac mice had higher muscle necro-
sis 3 days after HLI (Figures 7J–7K and S67A), and even though
the number of regenerating fibers was similar to their WT litter-
mates, muscle fiber cross-sectional area was lower inmct1DMac
mice (Figures 7J, 7L, S7A, and S7B). Also,mct1DMac muscle had
lower VEGF levels (Figure 7M). Together, these results show that
lactate uptake throughMCT1 does not only promote M2-like po-
larization but also instructs M2-like macrophage-dependent
revascularization upon HLI.
DISCUSSION
ECs contribute to tissue homeostasis and regeneration via an-
giocrine signaling (Augustin and Koh, 2017; Rafii et al., 2016).
Known organotypic angiocrine signals include secreted growth
factors as well as ligand/receptor interactions at the cell mem-
brane. For instance, the release of HGF and TGF-b1 from liver
sinusoidal ECs ensures spatiotemporal control of liver regenera-
tion after partial hepatectomy (Ding et al., 2010; Hu et al., 2014;
LeCouter et al., 2003). In the brain, neurotrophin-3 derived from
brain ECs sustains neural stem cell quiescence in addition to
membrane-bound Jagged-1 and Ephrin-B2 (Delgado et al.,
2014; Ottone et al., 2014). Here, we show that ECs also exploit
their unique metabolic features to engage in angiocrine commu-
nication. Within the muscle microenvironment, they shuttle
lactate as a metabolic substrate to promote macrophage polar-
ization. By doing so, ECs actively steer muscle regeneration after
hindlimb ischemia.
ECs are highly glycolytic and generate the majority of their en-
ergy via the glycolytic breakdown of glucose to lactate (Culic
et al., 1997; De Bock et al., 2013; Kr€utzfeldt et al., 1990; Schoors
et al., 2014; Xu et al., 2014; Yu et al., 2017). We found that mECs
use lactate as a ‘‘ready-to-sprout’’ signal to increase VEGF
secretion and promote muscle regeneration by instructing the
polarization of macrophages toward an M2-like phenotype in a
MCT1-dependent manner. Thus, through the release of lactate,
ECs themselves shape a pro-angiogenic environment to allow
optimal revascularization. Macrophage-derived VEGF subse-
quently consolidates a positive feedback loop, which leads to
a further angiogenic activation of mECs. Interestingly, restoring
VEGF levels in the muscle of pfkfb3DEC mice by promoting M2-
like macrophage polarization (through M2 macrophage transfer
or by increasing lactate levels) increased vascular density,
although the latter failed to reach pfkfb3WT levels upon lactate
administration. This indicates that the observed angiogenic(D) Lactate concentration in tibialis anterior muscle 5 days after injection of vegf
(E) Total number of macrophages determined by flow cytometry in muscle samp
(F and G) Representative histograms (F) and CD206 mean fluorescence intensity
(H and I) Representative laser Doppler perfusion images (H) and quantification of
lactate (lac) at the indicated times.
(J) Representative images of CD31 immunofluorescent staining and quantificatio
(K) VEGF protein content in muscle at 12 days.
(L) H&E staining of regenerating muscle (scale bar, 10 mm).
(M) Muscle fiber size distribution 12 days after HLI (n = 4).
Student’s t test (two-tailed, unpaired) in (D). Two-way ANOVAwith Tukey’s multip
(M) (*p < 0.05 versus pfkfb3WT; #p < 0.05 versus PBS). Two-way repeated-meas
represents a single mouse ([A], [B], [C], [D], [E], [G], [K], and [M]). Bar graphs repdeficit (at least in the ischemic muscle) is a combination of a
direct inhibitory effect of PFKFB3 on endothelial migration/prolif-
eration as well as reduced angiogenic stimulation by the muscle
microenvironment.
It is possible that the delivery of lactate also had a direct pro-
angiogenic effect in WT as well as pfkfb3DEC mice. In vitro,
lactate renders ECs more responsive to VEGF by increasing
VEGFR2 content due to enhanced HIF-1a stabilization (Son-
veaux et al., 2008; Ve´gran et al., 2011). Moreover, delivery of
lactate promoted, and inhibition of lactate uptake by blocking
MCTs reduced ischemia revascularization (Porporato et al.,
2012). Similar observations have been made in tumors (Son-
veaux et al., 2008). A potential contribution of macrophages to
this pro-angiogenic effect in vivo has, to our knowledge, not
been addressed. Although previous observations showed that
lactate delivery resulted in higher muscle fiber area after
ischemia (Porporato et al., 2012), our data revealed that lactate
by itself does not promoteMPCs proliferation or fusion, and it un-
derscores the ability of lactate to reshape macrophages (and
possibly other cells) in the muscle microenvironment to control
optimal regeneration.
We made the striking observation that loss of endothelial
pfkfb3 lowers muscle as well as plasma lactate levels upon hin-
dlimb ischemia. If anything, we expected that the presence of
highly glycolytic M1-like macrophages in combination with
higher hypoxia would lead to higher lactate levels in pfkfb3DEC
muscle. This suggests that mECs significantly contribute tomus-
cle lactate levels, which is surprising given the modest volume of
the endothelial population versus myofibers in muscle. In sup-
port of these observations, activation of angiogenesis in the
absence of muscle damage (via increasing VEGF) also resulted
into higher muscle lactate levels in pfkfb3WT when compared
to pfkfb3DEC mice. Lactate is a main carbon source for energy
production and can be shuttled between different cells or even
organs (Brooks, 2018; Hui et al., 2017). In the muscle, the pres-
ence of a lactate shuttle from glycolytic to oxidative muscle fi-
bers has been described for decades, predominantly in the
context of exercise (Bergman et al., 1999; Brooks, 1986; Stanley
et al., 1986). However, contribution of other cell types to lactate
metabolism in muscle has not been studied. Here, we demon-
strate the presence of a second lactate shuttling mechanism
within the muscle, i.e., from the endothelium to macrophages.
Endothelial-derived lactate promoted the functional polariza-
tion of macrophages, and this was dependent on lactate
uptake because its inhibition by using MCT1 inhibitors in vitro
or deletion of mct1 from macrophages in vivo prevented M2-
like polarization. Loss of MCT1 in macrophages decreasedoverexpressing myoblasts.
les at 3 days.
(MFI) (G) in total macrophages isolated from calf muscle 3 days after HLI.
blood perfusion ratio (I) (n = 7) in pfkfb3WT and pfkfb3DEC mice with or without
n of CD31-positive area in muscle at 12 days (n = 5–7; scale bar, 50 mm).
le comparisons test in (A), (B), (C), (E), (G), and (K) (*p < 0.05) as well as in (J) and
ures ANOVA with Sidak’s multiple comparisons test in (I) (*p < 0.05). Each dot
resents mean ± SEM. See also Figure S6.
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Figure 6. Lactate-Induced Macrophage Polarization Is MCT1 Dependent
(A) Lactate uptake in macrophages isolated from muscle 3 days after HLI.
(B) Lactate uptake in BMDMs after stimulation with mECs-CM. mECs-CM was supplemented with vehicle (ctrl), lactate, or MCT1 inhibitor AZD3965 (AZD)
(mECswt+AZD-CM, mECsDpfkfb3+AZD-CM).
(C) Lactate oxidation in BMDMs upon stimulation with mECswt-CM, mECsDpfkfb3-CM, mECswt+lac-CM, mECsDpfkfb3+lac-CM, mECswt+AZD-CM, and
mECsDpfkfb3+AZD-CM.
(D) Representative images of immunostainings for F4/80 (green), CD206 (red), and hoechst (blue) in BMDMs stimulated withmECswt+AZD-CMormECsDpfkfb3+AZD-
CM and flow cytometry quantification of CD206 MFI.
(E and F) Representative images (red, EdU+; blue, hoechst) (E) and quantification (F) of EdU+ MPCs.
(G and H) Representative DESMIN staining (red, DESMIN; blue, hoechst) (G) and fusion analysis (H) upon stimulation with mECs-CM/ BMDMs-CM.
(I) VEGF levels in mECs-CM/ BMDMs-CM.
Scale bar, 50 mm. Student’s t test (two-tailed, unpaired) in (A) (*p < 0.05). Two-way ANOVA with Tukey’s multiple comparisons test in (B), (C), (F), (H), and (I) (*p <
0.05) test and in (D) (*p < 0.05 versus mECswt-CM; #p < 0.05 versus ctrl). Each dot represents a single mouse (A) or the average of an independent experiment ([B],
[C], [F], [H], and [I]). Bar graphs represent mean ± SEM.
ll
OPEN ACCESS Article
1148 Cell Metabolism 31, 1136–1153, June 2, 2020
Figure 7. Loss of MCT1 in Macrophages Impairs M2-like Macrophage Polarization and Muscle Recovery from Ischemia
(A) Scheme showing the generation of LysM-Cre 3 mct1 Loxp/Loxp (mct1DMac) mice and HLI experiment.
(B) Mct1 mRNA expression in macrophages 3 days after HLI.
(legend continued on next page)
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muscle regeneration. Interestingly, angiocrine lactate sufficed
to increase macrophage oxygen consumption, a typical feature
of M2 macrophages (Pearce and Pearce, 2013). Also, M2-like
macrophages oxidized lactate, and lactate oxidation rate was
higher when compared to macrophages which were stimulated
with mECsDpfkfb3-CM. Gene profiling of macrophages isolated
from ischemic hindlimb of pfkfb3WT mice confirmed that genes
involved in OXPHOS were enriched, whereas this was not the
case in pfkfb3DEC mice. This shows that endothelial glycolysis
can contribute to metabolic reprogramming in macrophages
by providing additional substrates for oxidative phosphorylation.
We did not detect differences in baseline lactate levels inmuscle.
However, because lactate is continuously produced and
consumed by different cells, even under fully aerobic conditions
(Brooks, 1986; Hui et al., 2017), future research will be needed to
unravel the exact contribution of endothelial lactate to muscle
physiology.
The ability of lactate to control macrophage polarization
required conditioned medium, indicating that the presence
of other cytokines or metabolites was required for functional
repolarization. Raising lactate concentration to 5–10 mM suf-
ficed to induce M2-like skewing in the presence of condi-
tioned medium but failed to do so in the absence thereof.
This is in apparent contrast with previous observations in tu-
mor settings, where lactate itself sufficed to induce macro-
phage skewing via MCT-dependent uptake (Colegio et al.,
2014) or via acting as a signaling molecule through initiating
GPR132 signaling (Chen et al., 2017). It is worthwhile noting
that the lactate concentrations used in the present study
(5 mM) are within physiological ranges: exercising at high in-
tensity, even in mice (Ayachi et al., 2016), raises blood lactate
levels above 5–10 mM. We found an approximately 3-fold in-
crease in muscle lactate concentration 12 h after ischemia. In
addition, although adding lactate to the conditioned medium
restored the expression of CD206, not all M2 linked genes
were completely rescued. Also, expression levels of many
M2 genes were induced to a lower extent by lactate
compared to IL-4 despite similar CD206 membrane expres-
sion. This is not surprising, as in vivo transcriptional profiling
of macrophages upon cardiotoxin injury only showed partial
overlap with canonical M1/M2 profiles (Varga et al., 2016).
Nonetheless, lactate polarized macrophages recapitulated
many functional properties of IL-4-stimulated macrophages,
such as their pro-angiogenic properties (Jetten et al., 2014)
as well as their ability to promote muscle regeneration (Sac-
lier et al., 2013). Our current data therefore indicate that the
metabolic and transcriptional alterations induced by lactate(C) Total number of neutrophils, monocytes, and macrophages determined by flo
(D and E) Representative histograms showing CD206 (D) and Relma (E) express
(F) Quantification of CD206 and Relma MFI.
(G and H) Representative laser Doppler images (G) and quantification of hindlimb
(I) Representative images of CD31 immunostaining and quantification of CD31+
(J and K) H&E staining of regenerating muscle (scale bar, 10 mm) at the indicated
(L) Muscle fiber size distribution at 28 days (n = 4).
(M) VEGF protein content at 3 days.
Student’s t test (two-tailed, unpaired) in (B), (C), (F), (K), and (M) (*p < 0.05). Two
mct1WT). Two-way repeated-measures ANOVA with Sidak’s multiple comparison
[M]). Bar graphs represent mean ± SEM. See also Figure S7.
1150 Cell Metabolism 31, 1136–1153, June 2, 2020are sufficient to acquire pro-regenerative and pro-angiogenic
properties.
Macrophages are key regulators of muscle regeneration
(Dort et al., 2019). Initially, they have a pro-inflammatory M1-
like phenotype, which is associated with the expression of
several cytokines that further promote inflammation (Mosser
and Edwards, 2008). Rapidly thereafter, those M1-like macro-
phages repolarize and change their phenotype toward a more
anti-inflammatory, pro-angiogenic, and pro-regenerative M2-
like phenotype (Arnold et al., 2007; Mosser and Edwards,
2008; Raes et al., 2002). This M1 to M2 repolarization is
required for optimal muscle regeneration (Arnold et al.,
2007; Deng et al., 2012; Tidball and Wehling-Henricks,
2007). The contribution of ECs to macrophage differentiation
and maturation is poorly understood. ECs can promote
macrophage polarization in a contact-dependent manner (He
et al., 2012; Krishnasamy et al., 2017), but only limited evi-
dence exists which supports metabolic crosstalk between
macrophages and ECs. In the tumor microenvironment, low
glucose availability forces macrophages and ECs to compete
for glucose (Wenes et al., 2016). During hypoxia, tumor-asso-
ciated macrophages shift toward a more oxidative meta-
bolism and reduce glucose uptake. This increases glucose
availability for ECs, thereby promoting excessive angiogen-
esis (Wenes et al., 2016). Although we cannot exclude a
similar scenario being active in the ischemic hindlimb, our
data suggest that ECs and macrophages metabolically collab-
orate to promote muscle regeneration. They efficiently share
the available energetic substrate glucose via the glycolytic
breakdown to lactate by ECs followed by lactate oxidation
in macrophages.
In conclusion, we provide evidence that ECs exploit their
unique metabolic characteristics to steer muscle regeneration
during ischemia in an angiocrine fashion that is dependent on
lactate shuttling tomacrophages. Metabolic angiocrine signaling
provides a novel mechanism through which ECs can contribute
to tissue homeostasis and regeneration.
LIMITATIONS OF STUDY
Although our study shows that angiocrine lactate controls M2-
like macrophage polarization in an MCT1-dependent manner,
the exact molecular mechanism through which lactate drives
M2-like polarization remains to be unveiled. To further dissect
the kinetics of angiocrine metabolic crosstalk, it would be
insightful to have genetic mouse models to selectively uncou-
ple endothelial lactate secretion from angiogenesis. Further-
more, arteriogenic collateral formation also contributes tow cytometry in muscle 3 days after HLI.
ion.
perfusion (H) in mct1WT and mct1DMac (n = 7).
area 12 days after HLI (n = 6; scale bar, 50 mm).
time (J) and quantification of necrotic area (K) 3 days after HLI.
-way ANOVA with Tukey’s multiple comparisons test in (L) (*p < 0.05 versus
s test in (H) (*p < 0.05). Each dot represents a single mouse ([B], [C], [F], [K], and
ll
OPEN ACCESSArticlemuscle reperfusion upon hindlimb ischemia, but arteriogenesis
was not evaluated in this study.
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SYTOX Blue Thermo Fisher Scientific Cat#S34857
SYTOXTM Red Thermo Fisher Scientific Cat#S34859
Normal Donkey Serum Jackson Immuoresearch Cat#017-000-121
FGF-Basic (AA 1-155) Recombinant Human Protein Thermo Fisher Scientific Cat#PHG0266
Puromycin Sigma-Aldrich Cat#P8833
Deoxyribonuclease I Sigma-Aldrich Cat#D4527
Critical Commercial Assays
Mouse VEGF Quantikine ELISA Kit R&D Systems Cat#MMV00
Proteome Profiler Mouse XL Cytokine Array R&D Systems Cat#ARY028
HypoxyprobeTM Plus Kit Hypoxyprobe, Inc Cat# HP2-100Kit
Seahorse XF Cell Mito Stress Test Kit Agilent Cat#103015-100
DCTM Protein Assay Kit I Bio-Rad Cat#5000111
Clarity Western ECL Substrate Bio-Rad Cat#1705061
Lactate-GloTM assay Promega Cat#J5021
Click-iT Cell Reaction Buffer Kit Thermo Fisher Scientific Cat#C10269
Experimental Models: Organisms/Strains
Mouse: mct1fl/fl Cyagen Bioscience N/A
Mouse: Rosa26mTmG Muzumdar et al., 2007 https://www.jax.org/strain/007676
Mouse: LysMCre Clausen BE et al.,1999 N/A
Mouse: LysMCre-vegffl/fl Stockmann et al.,2008 N/A
Mouse: pfkfb3Loxp/Loxp This paper N/A
Mouse: pdgfb-CreERT2 Claxton et al., 2008 N/A
Metabolites
See Table S1 for LC-MS/MS mediated
determination of metabolites.
This paper N/A
Deposited Data
RNA-sequencing data This paper GSE148584
Oligonucleotides
See Table S2 for oligonucleotide sequences
used for real-time quantitative PCR.
This paper N/A
Software and Algorithms
FlowJo Software (version 10.4.2) Three Star https://www.flowjo.com/
ImageJ (for image analysis) NIH https://imagej.nih.gov/ij/
Prism 8 (version 8.0.0) GraphPad Software https://www.graphpad.com/
scientific-software/prism/
Adobe Illustrator CS6 (version 16.0.4) Adobe https://www.adobe.com/
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OPEN ACCESSArticleRESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Katrien De
Bock (katrien-debock@ethz.ch).
Materials Availability
This study did not generate new unique reagents.Cell Metabolism 31, 1136–1153.e1–e7, June 2, 2020 e2
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OPEN ACCESS ArticleData and Code Availability
Themouse RNA-seq data reported in this study are available at the Gene Expression Omnibus (GEO) repository under the accession
number (GSE148584). All other data are available from the Lead Contact on request.
EXPERIMENTAL MODELS
Mice
Pfkfb3LoxP/LoxP mice were generated using homologous recombination in embryonic stem (ES) cells. The targeting vector was built in
the pComTrue plasmid (Reich et al., 2011) (kindly provided by M. Baes, KU Leuven) with Frt sites flanking a neomycine resistance
(neor) cassette, and containing from 50 to 30: a 1.78-kb NotI fragment comprising exon 2, a floxed 4.4-kb AscI fragment comprising
exon 3, 4, 5 and 6 as 50 homology arm, a 1.2-kb Frt flanked neor cassette, and a 2.38-kb BamHI fragment comprising exon 7 as 30
homology arm. The construct was linearized with PmeI and electroporated into G4 ES cells of 129SvEv/C57BL6 origin (kind gift from
A. Nagy, Toronto) as described (Aragone´s et al., 2008). After positive-negative drug selection with 200 mg/mLG418 (Invitrogen), resis-
tant clones were analyzed for correct homologous recombination by appropriate Southern blotting and PCR. Correctly targeted ES
cells were then transiently electroporated with the Flp recombinase expressing plasmid pCAGGS-Flpe (Pieters et al., 2017) to excise
the neor cassette, and used formorula aggregation to generate chimeric and germline pfkfb3+/LoxP offspring. Genotyping on genomic
DNA from Flp-recombined ES cells and frommouse tails was done by PCR, using the forward primer 50-cac ctg agc aac att gta act-30
and reverse primer 50-cag gcc cag acc aag gac agc30, revealing a 185-bp and 300-bp amplicon for the wild type and floxed pfkfb3
allele, respectively.
To obtain inducible EC-specific pfkfb3-knockout (pfkfb3DEC) mice, pfkfb3LoxP/LoxP mice were intercrossed with pdgfb-CreERT2
mice, an EC-selective inducible Cre-driver line (Claxton et al., 2008). To evaluate recombination specificity, pdgfb-CreERT2 mice
were intercrossedwith Rosa26mTmGmice (Muzumdar et al., 2007). Recombination was induced in 8-14weeks oldmice by daily intra-
peritoneal administration of 1mg tamoxifen (T5648, Sigma-Aldrich) dissolved in 1:10 ethanol: corn oil solution for 5 consecutive days.
A wash out period of at least 7 days was allowed before starting the experiments. Tamoxifen-treated Cre-negative littermates were
used as control for all experiments.
To obtain myeloid cell specific deletion ofmct1 (Slc16a1), mice carrying floxed alleles formct1 (exon 5,mct1 LoxP/LoxP) were gener-
ated by Cyagen, Santa Clara CA, USA in collaboration with L. Pellerin, and intercrossed with LysM-Cre mice (Clausen et al., 1999).
LysM-Cre x Vegf LoxP/LoxP mice (Gerber et al., 1999; Stockmann et al., 2008) were obtained in collaboration with C. Stockmann.
Mice were randomly allocated to different treatment groups, and the investigator was blinded to the group allocation during
the experiment as well as during the analysis. Mice were housed in individually ventilated cages at standard housing conditions
(22C, 12 h light/dark cycle, dark phase starting at 7pm), with ad libitum access to chow diet (18% proteins, 4.5% fibers, 4.5%
fat, 6.3% ashes, Provimi Kliba SA) and water. Health status of all mouse lines was regularly monitored according to FELASA
guidelines. All animal experiments were approved by the local animal ethics committee (Kantonales Veterin€arsamt Z€urich,
licenses ZH123/17, and ZH014/16), and performed according to local guidelines (TschV, Zurich) and the Swiss animal protection
law (TschG).
Cell Culture
Isolated primary mouse skeletal muscle endothelial cells (mECs) were cultured in Endothelial Cell Growth Medium-2 (EGM2) (CC-
3162, Lonza, Basel, Switzerland) or in a 1:1 ratio of M199 ((11150059, ThermoFisher Scientific) supplemented with 20% fetal bovine
serum (FBS) (10270-106, ThermoFisher Scientific), 2mM L-glutamine (25030081, ThermoFisher Scientific) and 30 mg/L endothelial
cell growth factor supplements (EGCS) (E2759, Sigma-Aldrich)) and Endopan 3 (P04-0010K, PAN BIOTECH) (denoted as M/E).
Freshly isolated MPCs were cultured in a 1:1 ratio of DMEM (ThermoFisher Scientific, 12320032) and Ham’s F-10 (1X) nutrient
mix (22390058, ThermoFisher Scientific) supplemented with 10% horse serum (HS, 16050-122, ThermoFisher Scientific), 20%
FBS and 10 ng/mL basic-FGF (PHG0266, ThermoFisher Scientific) on dishes coated with Matrigel Basement Membrane Matrix
(#356237, Corning, 1:25 dilution). To inducemyogenic differentiation MPCswere seeded at 70,000 cells/well in 12-well plates coated
withMatrigel and cultured in differentiationmedium (low-glucose DMEM (22320022, ThermoFisher Scientific) supplementedwith 2%
HS) for 2 days. Bone-marrow precursor cells were differentiated into BMDMs in RPMI-1640 medium (31870025, ThermoFisher Sci-
entific) supplemented with 20 ng/mL recombinant M-CSF (315-02, PeproTech), 2mM L-glutamine (25030081, ThermoFisher Scien-
tific), 10mMHEPES (15630056, ThermoFisher Scientific), 50 mm 2-Mercaptoethanol (31350010, ThermoFisher Scientific), 10% FBS.
Medium was changed on day 3 and day 6. On day 7, adherent BMDMs were detached by washing the plates with cold DPBS
(14190250, ThermoFisher Scientific) with 2mM EDTA (E8008, Sigma) and used in experiments. All media was supplemented with
100 units/mL penicillin and 100 mg/mL streptomycin (15140122, ThermoFisher Scientific). Cells were routinely cultured at 37C in
21% O2 and 5% CO2. Cells were regularly tested for the presence of mycoplasma.
METHOD DETAILS
Isolation of Endothelial Cells
Primary ECs from skeletal muscle (mECs) were isolated from adult pfkfb3DEC and pfkfb3WT littermates. Mice were euthanized, all
hind-limb muscles were immediately dissected, and muscles were minced in a Petri dish on ice using a surgical blade. Next, thee3 Cell Metabolism 31, 1136–1153.e1–e7, June 2, 2020
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Steinheim, Germany), 2 mg/mL Collagenase IV (17104019, ThermoFisher Scientific, Massachusetts, USA) and 2 mM CaCl2 in
PBS at 37C for 40 min, with gentle shaking every 10 min. The reaction was stopped by adding an equal volume of 20% FBS in
HBSS and the suspension was passed through a series of 100-mm cell strainers (#352360, Corning, New York, USA) and 70-mm
cell strainers (#352350, Corning, New York, USA) to remove tissue debris. After a series of centrifugation and washing steps, the het-
erogeneous cell population was purified by FACS or by puromycin selection. For FACS, ECs were sorted based on positive CD31
staining and the absence of CD45 staining. For puromycin selection, the pellet was resuspended in EC culture medium and seeded
in collagen type I (125-50, Sigma)-coated plates. Due to the higher expression of P-glycoprotein in ECs compared to other skeletal
muscle cells, mECs were selected by adding 4 mg/mL puromycin (P8833, Sigma-Aldrich, St. Louis, USA) to the medium overnight.
After 7 days in culture, the purity of mECswas determined by CD31 fluorescence staining and only cultures containing at least 85%of
the cells positive for CD31 were used for further experiments.
Isolation Primary Myogenic Progenitor Cells (MPCs)
MPCs were extracted as described before (D’Hulst et al., 2020). In brief, muscle tissue was digested in HBSS supplemented with
1.5% bovine serum albumin (BSA) (9048-46-8, Pan Reac AppliChem) and 2 mg/mL collagenase type II (ThermoFisher Scientific,
17101015) for 1 h at 37C. After centrifugation, the cell pellet was then filtered using 100 and 40 mmcell strainers and a heterogeneous
cell population was purified by FACS. For FACS, MPCs were sorted based on positive alpha 7-integrin staining and the absence of
Sca1, CD31, and CD45 staining.
Isolation of Bone Marrow-Derived Macrophages (BMDMs)
Bone-marrow-derived macrophages (BMDMs) were obtained from bone-marrow precursor cells by flushing the femur and tibiae of
sex-matched 6 to 12-week old mice (Freigang et al., 2013).
Conditioned Medium (CM)
mEC-derived CM: mECs isolated from adult pfkfb3DEC and pfkfb3WT were cultured in 12-well plate and cultured until they reached
confluency (7 days). Medium was then refreshed with M/E medium and mECs were cultured in this media for 48 h. After 48 h the
culture medium was collected and filtered through a 0.2 mm filter (431219, brunschwig) to obtain conditioned medium (mECswt-
CM and mECsDpfkfb3-CM). Fractionation of the mECs-CM was achieved using Amicon Ultra centrifugal filters (3KUltracel, Millipore)
following centrifugation at 4,000 rpm for 1 h. The > 3kDa fraction was resuspended in unsupplemented M/E to equal the pre-filtration
volume of the CM. Macrophage-derived CM: BMDMs were seeded at 400,000 cells/well. When the cells were adherent (approxi-
mately 2 h later) medium was replaced with mEC-derived CM (see paragraph above) mixed in a 1:1 ratio with RPMI-1640 medium.
In some experiments, mEC-derived CM was supplemented with 5mM Sodium L-lactate (L7022, Sigma) and/or 250nM AZD3965
(1448671-31-5, Cayman Chemical) or DMSO as a control. After 48 h, the polarized BMDMs were briefly washed, and MPC growth
medium or differentiation medium was added for 24 h to generate the BMDM-derived CM. Thereafter, the culture medium (mECswt-
CM/BMDMs-CM, mECsDpfkfb3-CM/BMDMs-CM, mECswt+lac-CM/BMDMs-CM, mECsDpfkfb3+lac-CM/BMDMs-CM,
mECswt+AZD-CM/BMDMs-CM, mECsDpfkfb3+AZD-CM/BMDMs-CM) was collected as described above.
MPCs Proliferation
MPCswere seeded at 100,000 cells/well per well in a 12-well plate inMPC growthmedia. As ameasure of proliferation, incorporation
of 5-ethynyl-2’-deoxyuridine (EdU) was assessed using the Click-iT Cell Reaction Buffer Kit (C10269, ThermoFisher Scientific, Mas-
sachusetts, USA) according to themanufacturer’s instructions. Briefly, MPCswere incubated under standard growth conditions with
10 mMEdU for 2 h. Thereafter, cells were fixed with 4% PFA for 10 min at room temperature and washed twice with 3% BSA in PBS.
Cells were permeabilized for 20min at room temperature in 0.5% Triton X-100 with 3%BSA in PBS, then washed twice with 3%BSA
in PBS and incubated with the Click-iT reaction cocktail for 45 min in the dark at room temperature. Thereafter, cells were briefly
washed and counterstained with Hoechst (#62249, ThermoFisher Scientific). MPCs were imaged using an AxioObserver.Z1 fluores-
cence microscope (Carl Zeiss, Oberkochen, Germany). The percentage of EdU-positive MPCs was calculated in at least 15
random fields.
Fusion Determination
MPCs were seeded at 70,000 cells/well per well in a 12-well plate and cultured in differentiation media for 48 h (see cell culture sec-
tion). Myotubes were fixed with 2% PFA for 5 min at room temperature and washed twice with PBS. Cells were blocked for 30 min at
room temperature in blocking buffer (PBS supplemented with 0.5% Triton X-100 and 2% BSA) and subsequently incubated with an-
tibodies against DESMIN (5332, Cell Signaling, 1:100) diluted in blocking buffer for 1 h at room temperature. After washing, cells were
incubated with secondary antibody (goat anti-rabbit conjugated to Alexa Fluor 568, A11011, ThermoFisher Scientific, 1:400) diluted
in blocking buffer for 1 h. Thereafter, cells were counterstainedwith Hoechst. The number of nuclei permyotubewas then determined
by counting the number of Hoechst+ nuclei per DESMIN-positive myotube (only DEMSIN+myotubes with 3 or more nuclei cells were
considered).Cell Metabolism 31, 1136–1153.e1–e7, June 2, 2020 e4
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Hind-limb ischemia experiments were performed as described before with minor modifications (Limbourg et al., 2009; Zhang et al.,
2017). Briefly, mice were anesthetized with isoflurane, the hind limb was shaved, and, following a small incision in the skin, both the
proximal end of the femoral artery and the distal portion of the saphenous artery were ligated. The artery and all side-branches were
dissected free; after this, the femoral artery and attached side-branches were excised. Immediately after surgery, perfusion was
measured by Laser Doppler Imaging of plantar regions of interest (Moor Instruments Ltd, Axminster, Devon, England) and calculated
as ratio of left (ligated) versus right (unligated) values. For lactate rescue experiments in vivo, a 100 mL plug of growth factor-reduced
Matrigel (BD Biosciences) supplemented with 150 mM rotenone (Sigma) containing 150 mM sodium L-lactate (Sigma) (Lactate) or an
equal volume of PBS (control) was directly implanted adjacent to the lesion during the ligation surgery, as described (Porporato et al.,
2012). For macrophage transfer experiments, BMDMs were freshly isolated (see isolation and culture of BMDM section) and stim-
ulated with IL-4 (20ng/mL; PeproTech) or vehicle (0.1% BSA) for 2 days. Then, 5 3 105 cells diluted in 50mL DPBS were injected
into recipient calf muscles 3 days after HLI. For EdU labeling, mice were i.p. injected with 1.25mg EdU (LifeTechnologies) 20 h before
tissue collection.
For myoblast transfer experiments, VEGF or LacZ/control overexpressing myoblasts (Ozawa et al., 2004) were dissociated in
trypsin and resuspended at a concentration of 108 cells/mL in sterile PBS with 0.5% BSA, and 106 myoblasts were injected into
Tibialis anterior (TA) muscles of pfkfb3WT and pfkfb3DEC mice, respectively.
Immunohistochemistry and Histology
Calf muscle samples were harvested and embedded in Tissue-Tek and frozen in liquid N2-cooled isopentane. Skeletal muscle cry-
osections (10 mm) were fixed in ice-cold acetone for 5 min, washed twice with PBS and subsequently incubated for 1 h in blocking
buffer (PBS with 1%BSA) at room temperature. Thereafter, samples were incubated overnight at 4Cwith primary antibodies diluted
in blocking buffer with or without addition of 0.1%Triton X-100. The following primary antibodies were used: anti-CD31 (AF3628, R&D
Systems, 1:250), anti-F4/80 (ab6640, Abcam, 1:200), anti-laminin (PA1-16730, Thermo Fisher, 1:250), anti-MRC1/CD206 (ab64693,
Abcam, 1:50), cleaved caspase-3 (#9661, Cell Signaling, 1:100), anti-Ki67 (#9129S, Cell Signaling, 1:200). Slides were subsequently
washed in PBS and incubated for 1 h in blocking buffer with the appropriate secondary antibodies at 1:250 dilution. Nuclei were
stained with Hoechst. Muscle hypoxia was detected with HypoxyprobeTM Plus Kit (Hypoxyprobe, Inc, HP2-100Kit) according to
the manufacturer’s protocol. Briefly, mice received an intraperitoneal injection of 100 mg/kg pimonidazole HCl (20 mg/mL in 0.9%
NaCl). One h after injection, muscles were collected and frozen as described above. Hypoxyprobe was detected by incubating
the samples with anti-pimonidazole FITC-conjugated mouse IgG1 monoclonal antibody (FITC-Mab1) and rabbit anti-FITC conju-
gated with horseradish peroxidase. H&E staining was used to quantify the necrotic and regenerating muscle fibers. Tissue necrosis
was identified by morphological alterations of myofibers or loss of sarcolemmal integrity and by the presence of cellular debris and
many mononuclear cell infiltrates in the surrounding interstitial space. Regenerating areas were identified by the dominant presence
of fibers with centrally located nuclei and/or some remaining mononuclear cell infiltrates. For immunostaining of whole-mounted
muscle bundles, gastrocnemius muscle was fixed in 2% PFA for 1 h at 4C, and washed with PBST (0.2% Triton X-100 in PBS).
A small bundle of muscle was carefully dissected by fine forceps from the center portion of the calf muscle. The muscle tissues
were then blocked with 1% BSA in PBST for 1 h at room temperature. The tissues were incubated rocking at 4C for 48 h with
anti-CD31 (1:100) antibody. Subsequently, tissues were washed overnight in PBS at 4C, followed by incubation with secondary an-
tibodies (1:250) overnight at 4C. Imageswere capturedwith a Zeiss Axio observer Z.1 or anOlympus confocal microscope (FV1200).
Fiber cross-sectional area was automatically determined on laminin stained sections with the Muscle J plugin for ImageJ software
(Mayeuf-Louchart et al., 2018). In themyoblast injection experiment, vascular density (%CD31+ area) was quantified within the areas
of myoblast implantation with ImageJ software after threshold processing on 20x images acquired with a Nikon Eclipse Ti2 micro-
scope (Nikon, Egg/Z€urich, Switzerland).
RNA Extraction and Quantitative RT-PCR
RNA of mECs and BMDMs was extracted using a RNeasy Plus Micro Kit according to the manufacturer’s instructions (QIAGEN,
74034). RNA purity and concentration were assed via a spectrophotometer (Tecan, Spark). RNA was reverse-transcribed to
cDNA by High Capacity cDNA Reverse Transcription Kit (Thermo Fisher, 43-688-13). A SYBR Green-based master mix
(ThermoFisher Scientific, A25778) was used for real-time qPCR analysis with primers listed in Table S2. To compensate for variations
in RNA input and efficiency of reverse-transcription, 18S was used as a housekeeping gene. The delta-delta CT method was used to
normalize the data.
RNA Sequencing and Differential Gene Expression Analysis
RNA sequencing was performed by Funcional Genomics Center Zurich (FGCZ). The quality and quantity of isolated RNA and final
libraries were determined using Qubit (1.0) Fluorometer and the Tapestation (Agilent, Waldbronn, Germany). Sequencing libraries
were prepared following SMARTer Universal Low Input RNA Kit for Sequencing. Briefly, total RNA samples (0.25–10 ng) were
reverse-transcribed using random priming into double-stranded cDNA in the presence of a template switch oligo (TSO). Ribosomal
cDNAwas cleaved by ZapR in the presence of themammalian-specific R-Probes. Remaining fragments were enrichedwith a second
round of PCR amplification using primers designed tomatch Illumina adapters. The product is a smear with an average fragment size
of approximately 360 bp. The libraries were normalized to 10nM in Tris-Cl 10 mM, pH8.5 with 0.1% Tween 20. For mapping ande5 Cell Metabolism 31, 1136–1153.e1–e7, June 2, 2020
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Alignment to the Ensembl reference genome GRCm38 was performed using the Hisat2 aligner. Gene expression values
were computed with the function featureCounts from the R package Rsubread. Aminimum expression of each gene (mean of counts
> 1) was applied as a cut off before analysis. Differential gene expression was computed usingNegative Binomial model implemented
in the Bioconductor package DESeq. Significantly differentially expressed genes was defined as a pvalue < 0.01 with a false discov-
ery ratio (FDR) < 0.1. FDR values were calculated using the Benjamini–Hochberg method. Pathway analysis was performed using the
clusterProfiler R package.
Immunoblot Analysis
Cells were collected and lysed with [50 mM Tris–HCl pH 7.0, 270 mM sucrose, 5 mM EGTA, 1 mM EDTA, 1 mM sodium orthovana-
date, 50mMglycerophosphate, 5mMsodiumpyrophosphate, 50mMsodium fluoride, 1mMDTT, 0.1%Triton X-100 and a complete
protease inhibitor tablet (Roche Applied Science)]. Lysates were centrifuged at 10000 g for 10min at 4C. Supernatant was collected,
and protein concentration was measured using the DC protein assay kit (5000116, Bio-rad). 5-10 mg of total protein was loaded in a
10-well pre-casted gradient gel (456-8086, Bio-Rad). After electrophoresis, a picture of the gel was taken under UV-light to determine
protein loading using stain-free technology. Proteins were transferred onto a PVDF membrane (Bio-rad, 170-4156) with a semi-
dry system and subsequently blocked for 1 h at room temperature with 5% milk in 0.1% TBS-Tween. Membranes were incubated
overnight at 4C with primary antibodies listed in Key Resources Table. The appropriate HRP-linked secondary antibodies (see
Key Resources Table) were used for chemiluminescent detection of proteins. Membranes were scanned with a Chemidoc imaging
system (Bio-rad) and quantified using Image Lab 6 software (Bio-rad).
Enzyme-Linked Immunosorbent Assay (ELISA)
Skeletal muscle tissue samples (10-15 mg) were homogenized with a tissue homogenizer (Omni THq) in ice-cold lysis buffer
(1:15 w/v) as described above. Homogenates were centrifuged at 10000 g for 10 min at 4C, and VEGF was measured in the super-
natants using the Mouse VEGF Quantikine ELISA Kit (R&D System, MMV00) according to the manufacturer’s protocol. The same kit
was used to measure VEGF levels in BMDMs-derived CM.
In Vitro Chemokine Measurement
Chemokine expression levels in the culture supernatants weremeasured using the Proteome Profiler Mouse XL Cytokine Array (R&D,
ARY028). 400 mL of culture supernatants were applied to each membrane. The results were further normalized to the protein
concentrations of the endothelial cell lysates. Staining and exposure were performed according to the manufacturer’s instructions.
Membranes were scanned with a Chemidoc imaging system (Bio-rad) and quantified using Image Lab 6 software (Bio-rad).
Metabolism Assays
Lactate levels: Lactate concentration in the medium, tissue or blood was determined using the Lactate-Glo Assay (Promega) or L-
Lactate Assay kit (Abcam) according to the manufacturer’s protocol. Glycolytic flux: Glycolytic flux measurements were performed
as previously described (Veys et al., 2019). Briefly, cells were incubated for 2 h in culture medium containing D-[5-3H(N)]-glucose
(NET53100, PerkinElmer, Zaventem, Belgium) at a final concentration of 0.4 mCi/mL medium. The supernatant was then transferred
into glass vials sealed with rubber stoppers, and 3H2Owas captured in hanging wells using a H2O-soakedWhatman paper for 48 h at
37C to reach saturation. Radioactivity in 3H-labeled paper was determined by liquid scintillation counting (LSC) and the glycolytic
flux was measured by the rate of 3H2O production.
14C-Lactate uptake: Cells were incubated for 6 h in RPMI containing 1 mCi/mL
L-[14C(U)] - Lactic Acid, Sodium Salt (NEC599050UC, PerkinElmer, Zaventem, Belgium) and 5 mM sodium lactate. Cells were
washed and lysed with 1 N NaOH at room temperature for 30 min and the radioactivity in the homogenate was determined by
LSC. 14C-Lactate oxidation: Cells were incubated for 6 h in RPMI containing 1 mCi/mL L-[14C(U)] - Lactic Acid, Sodium Salt
(NEC599050UC, PerkinElmer, Zaventem, Belgium) and 5 mM sodium lactate. Thereafter, 2 M perchloric acid was added to each
well to stop cellular metabolism, andwells were immediately covered with a 1 x hyamine hydroxide-saturatedWhatman paper. Over-
night absorption of 14CO2 released during the oxidation of lactate into the paper was performed at room temperature, and radioac-
tivity in the paper was determined by LSC. Extracellular acidification rate (ECAR) and oxygen consumption (OCR) were determined
using a Seahorse XF-96 Extracellular Flux Analyzer (Seahorse Bioscience). BMDMs were seeded at 100,000 cells/well in 96-well
plates and treated with mEC-derived CM supplemented with lactate or AZD3965 overnight. The assay medium was unbuffered
RPMI-1640 supplemented with 10 mM glucose, 1 mM pyruvate, and 2 mM L-glutamine, pH 7.4. The measurements were performed
at 4.5-min intervals (30 s mixing, 1 min recovery, 3 min measuring) for 1.5 h. Baseline ECAR and OCR and their response to the indi-
cated compounds were determined. Inhibitors were used at the following concentrations: 2.5 mMoligomycin, 1.5 mMFCCP, 500 nM
rotenone, and 500 nM antimycin A (all from Seahorse Bioscience). Pathway analysis was performed using the clusterProfiler R
package.
Mass Spectrometry Analysis
Metabolite abundances were analyzed by liquid chromatography–mass spectrometry as previously described (Elia et al., 2019). In
brief, metabolites were resuspended in 60% acetonitrile. Metabolites were measured using a 1290 Infinity II HPLC (Agilent) coupled
to a 6470 triple quadrupole mass spectrometer (Agilent). Samples were injected onto an iHILIC-Fusion(P) column with theCell Metabolism 31, 1136–1153.e1–e7, June 2, 2020 e6
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0.100 mL min1. Data analysis was performed with MSD Chemstation Data Analysis (v.E.02.0.2.1431) or Agilent MassHunter
(v.B.0802 Build 8.2.8260.0) followed by an in-house-developed MATLAB script. Data is available in Table S1.
Flow Cytometry
Cells were incubated in PBS with the fixable viability dye eFluor 780 (65-0865-14, eBioscience) before antibody staining. Prior to
surface staining with antibodies, Fc gamma receptors were blocked by incubating cells with anti-CD16/CD32 antibodies (2.4G2,
homemade). Thereafter, cells were incubated with the appropriate primary antibodies (CD45, CD11b, Ly-6G, Ly-6C, F4/80, MERTK,
CCR2, CD64, MHCII, CD11c, and CX3CR1) diluted in FACS buffer (DPBS + 2% FCS) for 15 min. For CD206 and Relma intracellular
stainings, cells were fixed with 4% formalin, permeabilized in permeabilization buffer (DPBS + 2% FCS + 0.5% saponin), and sub-
sequently incubated with antibodies for 30 min on ice. The anti-Relma antibody was detected with an anti-rabbit secondary antibody
labeled with FITC (Southern Biotech). For EdU proliferation experiments, cells from EdU-injected mice were first stained with anti-
bodies for cell surface markers and subsequently labeled with the click-iT plus EdU Alexa Fluor 488 Flow Cytometry Assay Kit
(Life Technologies) according to the manufacturer’s instructions. Cells were analyzed with a LSRFortessa (BD Bioscience) flow cy-
tometer or sorted using a FACS Aria III (BD Bioscience) sorter. Data were analyzed using FlowJo 10 software (Tree Star). A complete
list of all antibodies and staining reagents used can be found in Key Resources Table. The gating strategies used for flow cytometry
plots are shown in Figure S2.
QUANTIFICATION AND STATISTICAL ANALYSIS
The images presented in the manuscript are representative of the data (quantification of image is approximately the group average)
and the image/staining quality. All data represent mean ± SEM. GraphPhad Prism software (version 8.0.0) was used for statistical
analyses. Investigators were always blinded to group allocation. When comparing two group means, Student’s t test was used in
an unpaired two-tailed fashion. For more than two groups, one-way ANOVA with Tukey’s multiple comparisons test was used
and for experimental set-ups with a second variable, two-way ANOVA with Tukey’s multiple comparisons test was used. The statis-
tical method used for each experiment is indicated in each figure legend. Asterisks in figure legends denote statistical significance.
For Laser Doppler imaging experiments, mice were compared using a two-way repeated-measures ANOVA with Sidak’s multiple
comparisons test. No experiment-wide multiple test correction was applied. p > 0.05 is considered non-significant (ns). p < 0.05
is considered significant (*).e7 Cell Metabolism 31, 1136–1153.e1–e7, June 2, 2020
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Figure S1. Endothelial PFKFB3 controls EC glycolysis and ischemia induced 
revascularization. Related to Figure 1. 
(A-B) Pfkfb3 mRNA (A) and PFKFB3 protein (B) levels (n=3) in isolated muscle 
endothelial cells from pfkfb3WT and pfkfb3'EC mice. PFKFB3 protein levels are 
corrected for E-ACTIN. The arrow indicates 50 kDa. (C-D) Representative images of 
immunostainings for CD31 (green) and laminin (red) (C) and quantification of CD31+ 
area (D) in pfkfb3WT and pfkfb3'EC muscle. (E) Flow cytometry based quantification of 
the CD31+CD45- endothelial cell population (% of total mononuclear population) in 
muscle of pfkfb3WT and pfkfb3'EC mice. (F-G) Extracellular acidification rate (ECAR) 
(F) and glycolytic flux (G) in mECs isolated from pfkfb3WT and pfkfb3'EC mice. (H-I) 
Representative images of CASPASE3 (red), CD31 (green) and hoechst (blue) 
immunostainings (H) and quantification (I) of CASPASE3+CD31+ cells in muscles 1 
day after HLI. (J) Quantification of efluor780+CD31+CD45- dead endothelial cells in 
the control leg and in ischemic muscle at the indicated times. (K) Quantification of 
CD31+ area on transverse cross sections of muscles harvested at the indicated times. 
(L) Quantification of anastomosis on longitudinal sections of muscles harvested 28 d 
after HLI. (M-O) Representative images of low magnification hematoxylin-eosin 
(H&E) stainings (M) and quantification of necrotic (N) and regenerating (O) areas at 
the indicated times. (P) Quantification of pimonidazole positive area 3 d after HLI. (Q) 
Quantification of Vegf gene expression levels in MPCs, isolated 3 d after HLI. Scale 
bar, 50 Pm. Student’s t test (two-tailed, unpaired) in A, D, E, F, G, I, J, L, P, Q (*p ≤ 0.05; 
ns, not significant). Two-way ANOVA with Tukey’s multiple comparisons test in K, N, 
O (*p < 0.05). Each dot represents a single mouse. Bar graphs represents mean ± 
SEM. 
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Figure S2. Endothelial PFKFB3 is crucial for M2-like polarization of 
macrophages in the muscle. Related to Figure 2. 
(A) Flow cytometry analysis (top) and quantification (bottom) of mGFP+CD31+ cell 
and mGFP+CD45+ cell distribution in the muscle of pdgfb-CreERT2 x rosamTmG mice and 
their WT littermates before and 3 d after HLI. ECs, CD31+; immune cells, CD45+; 
macrophages, CD45+CD11b+F4/80+CD64+Ly-6G-Ly-6C-. (B) Pfkfb3 gene expression 
in CD45+ cells sorted from pfkfb3WT and pfkfb3'EC muscle 12 h after HLI. (C) Gating 
strategy for neutrophils, monocytes and macrophages isolated from ischemic muscle 
at the indicated time. (D) F4/80 expression and cellular size (FSC-A) of macrophages 
(green) and monocytes (pink) gated as described in (C). (E) CCR2 and CX3CR1 
expression on monocytes (pink) gated as described in (C). (F) Flow cytometry analysis 
of EdU+ macrophage (Ly-6C-) and monocyte (Ly-6C+) isolated from ischemic muscle 
at the indicated time. Shown are representative FACS plots pre-gated on 
CD45+CD11c-MHC-II-Ly-6G-CD11b+CD64+F4/80+. (G) Quantification of EdU+ 
macrophages (% of total macrophages) in muscle at the indicated times after HLI 
determined by flow cytometry. (H) Quantification of EdU+ CD206+ macrophages and 
EdU+ CD206- macrophages in muscle 72 h after HLI. Student’s t test (two-tailed, 
unpaired) in B (*p < 0.05). Two-way ANOVA with Tukey’s multiple comparisons test in 
G, H (*p < 0.05). Each dot represents a single mouse (B, G, H). Bar graphs represents 
mean ± SEM. 
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Figure S3. Endothelial PFKFB3 is crucial for M2-like polarization of 
macrophages in the muscle. Related to Figure 2. 
(A-B) Gene ontology (GO) (A) and KEGG (B) pathway analysis for cellular 
components on macrophages isolated from ischemic muscles 3 d after HLI.  
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Figure S4. Restoring M2 macrophage content in muscle of pfkfb3'EC mice 
improves muscle perfusion and regeneration. Related to Figure 3. 
(A) VEGF secretion by BMDMs after stimulation with IL-4. (B) Representative low 
magnification images of hematoxylin-eosin (H&E) staining (scale bar, 50 µm).  
Student’s t test (two-tailed, unpaired) in A (*p < 0.05). Each dot represents an 
independent experiment (A). Bar graph represents mean ± SEM. 
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Fig. S5. Endothelial lactate controls macrophage polarization and function upon 
muscle ischemia. Related to Figure 4. 
(A) Schematic illustration of co-culture of mECs with BMDMs. (B) Gene profiling of 
CD11b+F4/80+ BMDMs 24 h after co-culture of BMDMs with mECs isolated from 
pfkfb3WT and pfkfb3'EC mice. (C-D) Arg1 (C) and mgl1 (D) gene expression in BMDMs 
after stimulation with IL-4 or mECs-CM. (E) Quantification of CD206 mean 
fluorescence intensity (MFI) in BMDMs by flow cytometry after stimulation with IL-4 or 
mECs-CM. (F-G) Representative images (F) and heat map analysis (G) of cytokine 
profile array of mECswt –CM and mECs'pfkfb3-CM. (H-I) Gene expression analysis of 
mgl1 (H) and mgl2 (I) in BMDMs upon incubation with CM derived from mECwt or 
mEC'pfkfb3. (J) Lactate concentration in CM derived from scr, ldha and mct4 
knockdown HUVECs. (K) Gene expression analysis of M2 markers in BMDMs 
stimulated with scr, ldha and mct4 knockdown HUVEC-derived CM. (L) Arg1 gene 
expression BMDMs cultured in the presence of increasing concentrations of lactate. 
(M) Flow cytometry based quantification of CD206 mean fluorescence intensity (MFI) 
in BMDMs cultured in the presence of increasing concentrations of lactate. (N) 
Maximal oxygen consumption rate (OCR) of BMDMs after mECswt-CM, mECs'pfkfb3-
CM, mECswt+lac-CM, mECs'pfkfb3+lac-CM, mECswt+AZD-CM, mECs'pfkfb3+AZD-CM 
stimulation. (O-P) MPC proliferation measured as percentage of EdU+ cells (O) and 
fusion analysis after DESMIN labeling (P) in the presence of increasing 
concentrations of lactate. One-way ANOVA with Tukey’s multiple comparisons test in 
B, C, D, E, J, K, L, M, O, P (*p < 0.05).  Two-way ANOVA with Tukey’s multiple 
comparisons test in G, H, I, N (*p < 0.05). Each dot represents an independent 
experiment. Bar graphs represents mean ± SEM.  
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Fig. S6. Increasing muscle lactate levels in pfkfb3'EC mice restores M2 
macrophage content and improves muscle reperfusion and regeneration. 
Related to Figure 5. 
(A-B) Representative images of CD31 immunofluorescent staining (A) and 
quantification of CD31+ area (B) in muscle 12 d after vegf overexpression myoblast 
injection. (C) Schematic illustration of lactate (lac) explant experiments. (D) Lactate 
concentration in serum of pfkfb3WT and pfkfb3'EC mice obtained 3 d after HLI treated 
with PBS (control) or lactate. (E-F) Representative low magnification images of 
hematoxylin-eosin (H&E) staining (E) and quantification of regenerating area (F) 12 
days after HLI. Scale bar, 50 Pm. Two-way ANOVA with Tukey’s multiple comparisons 
test in B, D, F (*p < 0.05). Each dot represents a single mouse (B, D, F). Bar graphs 
represents mean ± SEM. 
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Fig. S7. Loss of MCT1 in macrophages impairs M2-like macrophage polarization 
and muscle recovery from ischemia. Related to Figure 7. 
(A-B) Representative low magnification images of hematoxylin-eosin (H&E) staining 
at the indicated time points (A) and quantification of regenerating area (B) 28 d after 
HLI. Student’s t test (two-tailed, unpaired) in B (*p < 0.05). Each dot represents a single 
mouse (B). Bar graphs represents mean ± SEM. 
 
 
 
 
 
 
Table S1. LC-MS/MS mediated determination of metabolites in conditioned 
media collected from wt and 'pfkfb3 mECs after culturing at confluence for 2 
days (n=3). Related to Figure 5. 
metabolites pfkfb3WT (mean ± SEM) pfkfb3'EC (mean ± SEM) 
succinate 16.80 ± 7.60 30.20 ± 6.88 
fumarate 5.83 ± 1.58 7.37 ± 0.29 
citrate 13.33 ± 2.24 10.07 ± 1.86 
glutamate 316.73 ± 66.48 283.23 ± 51.12 
malate 18.90 ± 1.00 21.73 ± 1.03 
a-KG 1.07 ± 0.61 1.233 ± 0.28 
arginine 12.93 ± 0.48 12.27 ± 0.32 
aspartate 287.27 ± 27.2 260.3 ± 41.16 
 
  
Table S2. Sequences of primers used for RT-PCR. Related to Figure 4 and Figure 
S5 . 
gene Forward  reverse 
18s AGTCCCTGCCCTTTGTACACA CGATCCGAGGGCCTCACTA 
pfkfb3 TATGAAGCCAGCTACCAGCC TCTGGATGTGGTCCTGCAC 
il-1E AGTTGACGGACCCCAAAAG AGCTGGATGCTCTCATCAGG 
tnfD CTCTTCTGTCTACTGAACTTCGG AAGATGATCTGAGTGTGAGGGT 
cxcl10 GCTGCCGTCATTTTCTGC TCTCACTGGCCCGTCATC 
sdf1 CCAAACTGTGCCCTTCAGAT ATTTCGGGTCAATGCACACT 
cxcr4 TGGAACCGATCAGTGTGAGT GGGCAGGAAGATCCTATTGA 
arg1 CCACAGTCTGGCAGTTGGAAG GGTTGTCAGGGGAGTGTTGATG 
nrp1 TCCTGGGAAACTGGTATATCTATGA CATTCCAGAGCAAGGATAATCTG 
vegf CTTGTTCAGAGCGGAGAAAGC ACATCTGCAAGTACGTTCGTT 
pdgfb AGCAGAGCCTGCTGTAATCG GGCTTCTTTCGCACAATCTC 
mgl1 CAGAATCGCTT AGCCAATGTGG TCCCAGTCCGTGTCCGAAC 
mgl2 TTCAAGAATTGGAGGCCACT CAGACATCGTCATTCCAACG 
mrc1 CTCTGTTCAGCTATTGGACGC CGGAATTTCTGGGATTCAGCTTC 
ldha TCTCTGTAGCAGATTTGGCAGA AAGACATCATCCTTTATTCCGTAAA 
mct4 AGCAGGTATCCTTGAGACGG GATGGCAAAGCAGATGGTGT 
mct1 GGGCTAAAGCCACAGTCCAT TCTGCTAAGTGCCACACAGG 
 
